| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/02/2001 | WO2001054704A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 08/02/2001 | WO2001054690A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses |
| 08/02/2001 | WO2001054659A2 Slimming cosmetic composition comprising a plant extract containing a plant natriuretic peptide (pnp) |
| 08/02/2001 | WO2001054653A1 Galenic formulation |
| 08/02/2001 | WO2001016114A3 Heterocyclic compounds and methods for modulating cxcr3 function |
| 08/02/2001 | WO2001012189A8 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | WO1999066918A8 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010011072 Skin disorders; kidney and liver disorders |
| 08/02/2001 | US20010010935 Useful in treating stem cells in a patient undergoing chemotherapy |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | DE19955349A1 Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen Use of polypeptides or nucleic acids encoding them for the diagnosis or treatment of skin disorders and their use for the identification of pharmacologically active substances |
| 08/02/2001 | DE10011926A1 Genetisch veränderte Fibroblastenzellen Genetically modified fibroblast cells |
| 08/02/2001 | DE10003786A1 Galenische Formulierung Drug formulation |
| 08/02/2001 | DE10003620A1 Non-aqueous solution or suspension of 5-aminolevulinic acid, is useful in the treatment or diagnosis of tumor diseases or psoriasis by photodynamic therapy |
| 08/02/2001 | CA2401590A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 08/02/2001 | CA2401086A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | CA2398728A1 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | CA2398660A1 Human cyr61 |
| 08/02/2001 | CA2398631A1 Slimming cosmetic composition comprising as an ative agent a plant extract containing a plant natriuretic peptide (pnp) |
| 08/02/2001 | CA2398561A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398358A1 The neurosteroid dhea as a marker for neuropathologies |
| 08/02/2001 | CA2397493A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | CA2397267A1 Peptide fragments and uses thereof as type-1 interferon antagonist |
| 08/01/2001 | EP1120114A2 Compositions and methods for treating conditions responsive to estrogen |
| 08/01/2001 | EP1120113A2 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormone |
| 08/01/2001 | EP1120108A1 Skin preparations for external use |
| 08/01/2001 | EP1119643A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-$g(a) (TNF-$g(a)) EXPRESSION |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119573A2 Bipyridine manganese complexes |
| 08/01/2001 | EP1119568A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/01/2001 | EP1119555A1 Biphenylene lactams as prostaglandin receptor ligands |
| 08/01/2001 | EP1119551A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 08/01/2001 | EP1119550A1 2-substituted heterocyclic sulfonamides |
| 08/01/2001 | EP1119548A1 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 08/01/2001 | EP1119542A1 Prostaglandin receptor ligands |
| 08/01/2001 | EP1119538A1 Derivatives of phenantrene for medicinal use and a process for their preparation |
| 08/01/2001 | EP1119357A1 C3a receptor ligands |
| 08/01/2001 | EP1119355A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 08/01/2001 | EP1119354A1 Peripherally acting anti-pruritic opiates |
| 08/01/2001 | EP1119351A2 Use of catechol derivatives as proteinase inhibitors |
| 08/01/2001 | EP1119344A1 Method for prevention and/or cosmetic treatment of skin stripe and use in dermatology |
| 08/01/2001 | EP0975350B1 Use of an extract of alchemilla vulgaris |
| 08/01/2001 | EP0885013B1 Use of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses for the preparation of medicaments |
| 08/01/2001 | EP0862567B1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 08/01/2001 | EP0737074B1 Botulinum toxins for treating hyperhydrosis |
| 08/01/2001 | CN1306530A Paroxetine 10-camphorsulfonate for treament of CNS disorders |
| 08/01/2001 | CN1306515A Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1306436A Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/01/2001 | CN1306428A Inhibitors of transcription factor NF-KB |
| 08/01/2001 | CN1306426A Use of compounds for anti-pruritic activity |
| 08/01/2001 | CN1306422A Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for treatment or prevention of diseases characterized by abnormal cell proliferation |
| 08/01/2001 | CN1306413A Foaming compsn. for hair care |
| 08/01/2001 | CN1305846A Diseases-resistant skin-protecting cream and its preparing process |
| 08/01/2001 | CN1305845A Disinfecting powder 'Shufushuang' for skin |
| 08/01/2001 | CN1305827A Chinese patent medicine for treating ulcer diseases |
| 08/01/2001 | CN1305826A Medicine for removing ephelides |
| 08/01/2001 | CN1305822A Precription of 'Notoginseng-Fangcao' phenolic tincture |
| 08/01/2001 | CN1305791A Stretchable hood utensil contg. stretchable adhesive matrix at least in moisture state |
| 08/01/2001 | CN1069061C Film for preventing and treating hyperplastic scar and prepn. method thereof |
| 08/01/2001 | CN1069048C Health-care foods for acne removing and beautifying face |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases |
| 07/31/2001 | US6268365 Src family SH2 domain inhibitors |
| 07/31/2001 | US6268344 Associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ards. |
| 07/31/2001 | US6268342 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/31/2001 | US6268337 Methods for treating vascular disorders using activated protein C |
| 07/31/2001 | US6268334 Cells include cardiovascular cells, and the peptide may be delivered in a stent to treat or prevent restinosis. |
| 07/31/2001 | US6268120 Isoalloxazine derivatives to neutralize biological contaminants |
| 07/31/2001 | US6267977 Delivery of hydroxy carboxylic acids |
| 07/31/2001 | US6267973 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 07/31/2001 | US6267972 Cosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonists |
| 07/31/2001 | US6267971 Use of cinnamic acid or of its derivatives in a cosmetic firming composition |
| 07/31/2001 | CA2214713C Topical antimicrobial agents |
| 07/31/2001 | CA2121144C Oligonucleotides having chiral phosphorus linkages |
| 07/31/2001 | CA2118119C Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 07/31/2001 | CA2068763C Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| 07/31/2001 | CA2035951C Bilobalide derivatives, their applications and formulations containing them |
| 07/31/2001 | CA1341278C Combination of pyrimidine derivatives and retinoids in separate components to induce and stimulate hair growth and reduce hair loss |
| 07/31/2001 | CA1341276C Hyaluronic acid esters and salts |
| 07/26/2001 | WO2001053444A1 Antimicrobial compositions |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001053313A1 Antisense modulation of smad7 expression |
| 07/26/2001 | WO2001053295A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin |
| 07/26/2001 | WO2001053289A1 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053261A1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 07/26/2001 | WO2001052893A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | WO2001052892A2 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | WO2001052873A1 VEGETABLE OIL FOR PREPARING A COMPOSITION INHIBITING 5α- REDUCTASE ACTIVITY |